Neuberg Diagnostics Secures Rs 940 Cr Investment From Kotak Alt

Neuberg Diagnostics, a Chennai-based integrated diagnostics company, has secured a Rs 940 crore investment from Kotak Alt. This marks the largest-ever primary fundraiser in India's diagnostics sector, the company said in a press statement on Friday.

The company is recognised as a leader in genomics, newborn screening, and reproductive genomics, performing over 5,000 types of tests. 

Dr. GSK Velu, Founder and Managing Director of Neuberg Diagnostics, expressed enthusiasm about the milestone, stating, “We are thrilled to announce that Neuberg Diagnostics has secured an investment from Kotak Alt, marking a significant milestone in our journey toward becoming one of the largest diagnostics chains of Indian origin. This funding will enable us to enhance our capabilities in personalised medicine, integrated diagnostics, and inorganically expand our footprint across the country. As we prepare for an IPO, we remain committed to making high-quality diagnostics accessible to all, ensuring that our services continue to meet the evolving needs of clinicians and patients.”

Rahul Shah, Partner at Kotak Alt, emphasised the strategic importance of the investment. “We are excited to partner with Neuberg Diagnostics as they work to transform the diagnostics landscape in India. The investment reflects our confidence in Neuberg's vision and potential. We are confident that this strategic investment will play a key role in increasing the scale of Neuberg Diagnostics and help the company get ready for their upcoming IPO. This investment solidifies our commitment to supporting quality healthcare solutions that improve patient outcomes and accessibility,” he said.

o3 Capital served as the exclusive financial advisor to Neuberg Diagnostics for this  fundraiser.